Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Linsitinib | 3.1623 | uM | 7 | 5000.00 | 1699.69 | 5021.00 | 5706.50 | 0.8799 | 0.8588 |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 5763.00 | 5706.50 | 1.0099 | 1.0113 | |
| SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 5000.00 | 1699.69 | 5760.00 | 5706.50 | 1.0094 | 1.0107 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 7 | 5000.00 | 1699.69 | 5560.00 | 5706.50 | 0.9743 | 0.9705 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 7 | 5000.00 | 1699.69 | 5512.00 | 5706.50 | 0.9659 | 0.9607 |
| SK-BR-3 | Erlotinib | 1 | uM | 7 | 5000.00 | 1699.69 | 5650.00 | 5706.50 | 0.9901 | 0.9886 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 7 | 5000.00 | 1699.69 | 4646.00 | 5706.50 | 0.8142 | 0.7780 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 7 | 5000.00 | 1699.69 | 5781.00 | 5706.50 | 1.0131 | 1.0149 |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 5764.00 | 5706.50 | 1.0101 | 1.0115 | |
| SK-BR-3 | 17-AAG | 3.1623 | uM | 7 | 5000.00 | 1699.69 | 3547.00 | 5706.50 | 0.6216 | 0.5235 |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 5621.00 | 5706.50 | 0.9850 | 0.9828 | |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 1.00 | 5706.50 | 0.0002 | -0.9858 | |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 7.00 | 5706.50 | 0.0012 | -0.9569 | |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 5393.00 | 5706.50 | 0.9451 | 0.9364 | |
| SK-BR-3 | 17-AAG | 10 | uM | 7 | 5000.00 | 1699.69 | 3311.00 | 5706.50 | 0.5802 | 0.4646 |
| SK-BR-3 | 17-AAG | 0.0016596 | uM | 7 | 5000.00 | 1699.69 | 5421.00 | 5706.50 | 0.9500 | 0.9421 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 7 | 5000.00 | 1699.69 | 5475.00 | 5706.50 | 0.9594 | 0.9532 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 5000.00 | 1699.69 | 5704.00 | 5706.50 | 0.9996 | 0.9995 |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 5776.00 | 5706.50 | 1.0122 | 1.0139 | |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 7 | 5000.00 | 1699.69 | 5629.00 | 5706.50 | 0.9864 | 0.9844 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 7 | 5000.00 | 1699.69 | 5723.00 | 5706.50 | 1.0029 | 1.0033 |
| SK-BR-3 | Linsitinib | 1 | uM | 7 | 5000.00 | 1699.69 | 5406.00 | 5706.50 | 0.9473 | 0.9390 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 7 | 5000.00 | 1699.69 | 4210.00 | 5706.50 | 0.7378 | 0.6805 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 7 | 5000.00 | 1699.69 | 5657.00 | 5706.50 | 0.9913 | 0.9901 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 7 | 5000.00 | 1699.69 | 3249.00 | 5706.50 | 0.5694 | 0.4489 |